Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12426
Brookfield Infrastructure
BIPC
$4.64B
| $27.9K | ﹤0.01% |
643
-17,806
| -97% | -$692K |
2023 Q3
4 quarters
|
|
12427
Camden Property Trust
CPT
$11.3B
| $27.9K | ﹤0.01% |
226
-29,643
| -99% | -$3.51M |
2020 Q4
15 quarters
|
|
12428
SAB Biotherapeutics
SABS
$267M
| $27.8K | ﹤0.01% |
+10,305
| New | +$28.5K |
2024 Q3
0 quarters
|
|
12429
CALL
Fossil Group
FOSL
$418M
| $27.7K | ﹤0.01% |
23,700
-3,400
| -13% | -$3.99K |
2013 Q2
45 quarters
|
|
12430
Sportsman's Warehouse
SPWH
$44.6M
| $27.7K | ﹤0.01% |
10,219
-55,490
| -84% | -$132K |
2021 Q4
11 quarters
|
|
12431
PUT
KT
KT
$9.05B
| $27.7K | ﹤0.01% |
1,800
+200
| +13% | +$2.88K |
2024 Q1
2 quarters
|
|
|
MAXN
12432
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $27.7K | ﹤0.01% |
2,861
-6,865
| -71% | -$110K |
2020 Q3
16 quarters
|
|
12433
CALL
Nexa Resources
NEXA
$1.65B
| $27.6K | ﹤0.01% |
3,800
+200
| +6% | +$1.38K |
2021 Q4
11 quarters
|
|
|
TBHC
12434
PUT
DELISTED
The Brand House Collective
TBHC
| $27.6K | ﹤0.01% |
+12,600
| New | +$21.2K |
2024 Q3
0 quarters
|
|
12435
Main Street Capital
MAIN
$5.12B
| $27.6K | ﹤0.01% |
550
-8,499
| -94% | -$425K |
2022 Q3
8 quarters
|
|
12436
CALL
Erasca
ERAS
$5B
| $27.6K | ﹤0.01% |
10,100
+7,000
| +226% | +$19.7K |
2022 Q4
7 quarters
|
|
12437
PUT
Digi International
DGII
$2.81B
| $27.5K | ﹤0.01% |
1,000
-600
| -38% | -$15.8K |
2024 Q2
1 quarter
|
|
12438
PUT
Beam Global
BEEM
$25.1M
| $27.5K | ﹤0.01% |
5,600
-6,600
| -54% | -$36.1K |
2021 Q1
14 quarters
|
|
12439
Valaris
VAL
$5.69B
| $27.5K | ﹤0.01% |
493
-27,891
| -98% | -$1.83M |
2024 Q1
2 quarters
|
|
12440
PUT
Alto Neuroscience
ANRO
$930M
| $27.5K | ﹤0.01% |
+2,400
| New | +$29.4K |
2024 Q3
0 quarters
|
|
12441
PUT
Rockwell Medical
RMTI
$30.8M
| $27.4K | ﹤0.01% |
690
+510
| +283% | +$13.7K |
2022 Q4
7 quarters
|
|
|
GB
12442
CALL
DELISTED
Global Blue Group Holding
GB
| $27.4K | ﹤0.01% |
5,000
-100
| -2% | -$506 |
2023 Q2
5 quarters
|
|
12443
PUT
Plexus
PLXS
$7.27B
| $27.3K | ﹤0.01% |
200
+100
| +100% | +$12.1K |
2023 Q1
6 quarters
|
|
12444
CALL
Vista Gold
VGZ
$391M
| $27.3K | ﹤0.01% |
35,200
+3,200
| +10% | +$1.85K |
2023 Q4
3 quarters
|
|
|
SBT
12445
CALL
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $27.3K | ﹤0.01% |
+6,000
| New | +$32.7K |
2024 Q3
0 quarters
|
|
|
TFFP
12446
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $27.3K | ﹤0.01% |
+13,579
| New | +$26.7K |
2024 Q3
0 quarters
|
|
|
ATYR
12447
CALL
aTyr Pharma
ATYR
$27.8M
| $27.3K | ﹤0.01% |
15,500
+15,300
| +7,650% | +$27.8K |
2021 Q2
13 quarters
|
|
12448
PUT
Gorman-Rupp
GRC
$2.04B
| $27.3K | ﹤0.01% |
700
-500
| -42% | -$19.2K |
2022 Q4
7 quarters
|
|
12449
PUT
Standard BioTools
LAB
$283M
| $27.2K | ﹤0.01% |
14,100
-6,600
| -32% | -$12.9K |
2023 Q3
4 quarters
|
|
12450
PUT
UNIFI
UFI
$122M
| $27.2K | ﹤0.01% |
3,700
-4,900
| -57% | -$30.8K |
2022 Q3
8 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.